CRWV vs DHR: Which Is the Better Buy?
Side-by-side comparison of CoreWeave, Inc. and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-08-06.
CoreWeave, Inc. · Technology
$89.89
+24.6% upside to fair value
Med Conviction
Grade C+
VS
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
QuantHub Verdict
CRWV has more upside to fair value
(+24.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRWV |
DHR |
| Current Price |
$89.89 |
$195.98 |
| Fair Value Estimate |
$112.00 |
$211.54 |
| Upside to Fair Value |
+24.6%
|
+7.9%
|
| Market Cap |
$49.0B |
$138.7B |
| Forward P/E |
—
|
37.8x
|
| EV / EBITDA |
26.6x
|
22.8x
|
| Price / Sales |
7.9x
|
5.6x
|
| Price / FCF |
—
|
26.2x
|
| Revenue Growth YoY |
+111.6%
|
+3.7%
|
| Gross Margin |
69.4%
|
60.7%
|
| Operating Margin |
-2.6%
|
21.0%
|
| Return on Equity |
-33.5%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
-21.6%
|
3.81%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
CoreWeave is the leading neocloud, a GPU-specialized cloud infrastructure provider built to serve the compute-hungry demands of generative AI training and inference. Since its March 2025 IPO, revenue has scaled roughly 112% year over year to $2.08 billion in the first quarter of 2026, backed by a $99.4 billion contracted revenue backlog and marquee agreements with Microsoft, OpenAI, Meta, Anthrop…
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Accumulation Zones
| Metric |
CRWV |
DHR |
| Zone Low |
$84.00 |
$158.66 |
| Zone High |
$95.00 |
$179.81 |
| In Buy Zone? |
Yes
|
No
|